These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34813085)

  • 21. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Golimumab for the treatment of psoriatic arthritis.
    Yang H; Epstein D; Bojke L; Craig D; Light K; Bruce I; Sculpher M; Woolacott N
    Health Technol Assess; 2011 May; 15 Suppl 1():87-95. PubMed ID: 21609657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review on golimumab in the treatment of psoriatic arthritis.
    Urdaneta M; Jethwa H; Sultan R; Abraham S
    Immunotherapy; 2017 Sep; 9(11):871-889. PubMed ID: 28838285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A; Chimenti MS; Chimenti S
    Expert Opin Biol Ther; 2008 Mar; 8(3):363-70. PubMed ID: 18294106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evidence-based review of the mechanism of action, efficacy, and safety of biologic therapies in the treatment of psoriasis and psoriatic arthritis.
    Brezinski EA; Armstrong AW
    Curr Med Chem; 2015; 22(16):1930-42. PubMed ID: 25921645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1.
    Kristensen LE; Soliman AM; Papp K; Merola JF; Barcomb L; Wang Z; Eldred A; Behrens F
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e389-e392. PubMed ID: 35032356
    [No Abstract]   [Full Text] [Related]  

  • 29. Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment.
    Forman SB; Higginson R; Garrett AB
    J Drugs Dermatol; 2008 Oct; 7(10):972-3. PubMed ID: 19112763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy.
    Kamili Qu; Menter A
    J Drugs Dermatol; 2010 Jan; 9(1):57-60. PubMed ID: 20120426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab for psoriasis and psoriatic arthritis.
    Antoni C; Manger B
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S122-5. PubMed ID: 12463461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Benucci M; Gobbi FL; Guiducci S; Foti R; Mosca M; Goletti D
    Semin Arthritis Rheum; 2017 Oct; 47(2):183-192. PubMed ID: 28413099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
    Bongiorno MR; Pistone G; Doukaki S; Aricò M
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal.
    Yang H; Craig D; Epstein D; Bojke L; Light K; Bruce IN; Sculpher M; Woolacott N
    Pharmacoeconomics; 2012 Apr; 30(4):257-70. PubMed ID: 22283690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
    Ritchlin C; Rahman P; Kavanaugh A; McInnes IB; Puig L; Li S; Wang Y; Shen YK; Doyle MK; Mendelsohn AM; Gottlieb AB;
    Ann Rheum Dis; 2014 Jun; 73(6):990-9. PubMed ID: 24482301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are biologics combined with methotrexate better than biologics monotherapy in psoriasis and psoriatic arthritis: A meta-analysis of randomized controlled trials.
    Xie Y; Liu Y; Liu Y
    Dermatol Ther; 2021 May; 34(3):e14926. PubMed ID: 33655646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
    Menter A; Gottlieb A; Feldman SR; Van Voorhees AS; Leonardi CL; Gordon KB; Lebwohl M; Koo JY; Elmets CA; Korman NJ; Beutner KR; Bhushan R
    J Am Acad Dermatol; 2008 May; 58(5):826-50. PubMed ID: 18423260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risankizumab: First Global Approval.
    McKeage K; Duggan S
    Drugs; 2019 Jun; 79(8):893-900. PubMed ID: 31098898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report.
    Lu J; Tang S; Yu N; Yi X; Li Y
    J Int Med Res; 2020 Nov; 48(11):300060520969494. PubMed ID: 33161790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.